Chelsea Therapeutics, Inc. Announces Presentation of Northera™ (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting
CHARLOTTE, N.C., March 19, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that Dr. Stuart Isaacson, Clinical Associate Professor, Department of Neurology, Herbert Wertheim College of Medicine, Florida International University, will present results from Northera™ (droxidopa) Study 306 at the American Academy of Neurology (AAN) 65th Annual Meeting which is taking place March 16-23, 2013 in San Diego.